These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31256080)

  • 21. The significance of recurrent lung opacities in neonates on surfactant treatment for respiratory distress syndrome.
    Odita JC
    Pediatr Radiol; 2001 Feb; 31(2):87-91. PubMed ID: 11214692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early neonatal outcomes of volume guaranteed ventilation in preterm infants with respiratory distress syndrome.
    Guven S; Bozdag S; Saner H; Cetinkaya M; Yazar AS; Erguven M
    J Matern Fetal Neonatal Med; 2013 Mar; 26(4):396-401. PubMed ID: 23039373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants.
    Yen TA; Wang CC; Hsieh WS; Chou HC; Chen CY; Tsao PN
    Pediatr Neonatol; 2013 Oct; 54(5):330-4. PubMed ID: 23711674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is it safer to intubate premature infants in the delivery room?
    Aly H; Massaro AN; Patel K; El-Mohandes AA
    Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term outcomes of extremely preterm infants at discharge: a multicenter study from Guangdong province during 2008-2017.
    Wu F; Liu G; Feng Z; Tan X; Yang C; Ye X; Dai Y; Liang W; Ye X; Mo J; Ding L; Wu B; Chen H; Li C; Zhang Z; Rong X; Shen W; Huang W; Yang B; Lv J; Huo L; Huang H; Rao H; Yan W; Yang Y; Ren X; Wang F; Liu D; Diao S; Liu X; Meng Q; Wang Y; Wang B; Zhang L; Huang Y; Ao D; Li W; Chen J; Chen Y; Li W; Chen Z; Ding Y; Li X; Huang Y; Lin N; Cai Y; Han S; Jin Y; Wan Z; Ban Y; Bai B; Li G; Yan Y; Cui Q
    BMC Pediatr; 2019 Nov; 19(1):405. PubMed ID: 31685004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled nitric oxide in premature infants with the respiratory distress syndrome.
    Schreiber MD; Gin-Mestan K; Marks JD; Huo D; Lee G; Srisuparp P
    N Engl J Med; 2003 Nov; 349(22):2099-107. PubMed ID: 14645637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
    Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
    J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive high-frequency oscillatory ventilation versus nasal continuous positive airway pressure in preterm infants with moderate-severe respiratory distress syndrome: A preliminary report.
    Zhu XW; Zhao JN; Tang SF; Yan J; Shi Y
    Pediatr Pulmonol; 2017 Aug; 52(8):1038-1042. PubMed ID: 28672094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
    Gortner L; Bartmann P; Pohlandt F; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Bremer C; Jorch G
    Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bubble nasal CPAP, early surfactant treatment, and rapid extubation are associated with decreased incidence of bronchopulmonary dysplasia in very-low-birth-weight newborns: efficacy and safety considerations.
    Friedman CA; Menchaca RC; Baker MC; Rivas CK; Laberge RN; Rios EH; Haider SH; Romero EJ; Eason EB; Fraley JK; Woldesenbet M
    Respir Care; 2013 Jul; 58(7):1134-42. PubMed ID: 23106970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
    Bhutani VK; Bowen FW; Sivieri EM
    Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic lung disease of the very low birth weight infant--is it preventable?
    Ogawa Y
    Turk J Pediatr; 1998; 40(1):35-44. PubMed ID: 9673527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.